CN Stock MarketDetailed Quotes

300181 Zhejiang Jolly Pharmaceutical

Watchlist
  • 16.65
  • -0.34-2.00%
Market Closed Dec 13 15:00 CST
11.68BMarket Cap22.56P/E (TTM)

Zhejiang Jolly Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
39.59%2.04B
41.21%1.43B
35.75%672.9M
7.61%1.94B
8.97%1.46B
13.02%1.01B
12.81%495.7M
23.86%1.81B
24.66%1.34B
28.28%894.95M
Operating revenue
39.59%2.04B
41.21%1.43B
35.75%672.9M
7.61%1.94B
8.97%1.46B
13.02%1.01B
12.81%495.7M
23.86%1.81B
24.66%1.34B
28.28%894.95M
Other operating revenue
----
91.52%5.17M
----
-71.49%5.2M
----
-87.76%2.7M
----
151.25%18.23M
----
347.14%22.07M
Total operating cost
35.64%1.61B
37.12%1.13B
29.71%519.09M
2.27%1.58B
3.08%1.19B
7.01%820.54M
7.75%400.19M
20.17%1.54B
21.68%1.15B
25.27%766.82M
Operating cost
70.93%785.11M
72.01%533.86M
50.19%224.23M
15.45%613.34M
19.23%459.31M
19.28%310.37M
21.37%149.29M
27.60%531.26M
25.02%385.24M
33.68%260.21M
Operating tax surcharges
28.58%21.22M
33.25%16.02M
12.52%4.95M
22.60%24.98M
12.20%16.5M
10.89%12.02M
-2.86%4.4M
11.74%20.37M
5.30%14.71M
7.36%10.84M
Operating expense
14.41%684.12M
16.07%488.28M
20.04%250.54M
-6.43%777.49M
-4.36%597.94M
1.58%420.67M
0.48%208.72M
17.27%830.87M
18.57%625.19M
20.78%414.12M
Administration expense
14.56%77.42M
20.30%53.43M
13.31%25.82M
6.75%96.69M
-6.43%67.58M
-4.79%44.41M
-0.44%22.79M
5.62%90.58M
22.44%72.22M
10.86%46.65M
Financial expense
38.35%-6.91M
23.43%-5.64M
68.33%-1.02M
-380.61%-14.25M
-324.64%-11.21M
-337.22%-7.37M
-301.96%-3.22M
-44.76%5.08M
-30.70%4.99M
-43.05%3.11M
-Interest expense (Financial expense)
9.02%6.56M
4.73%4.1M
26.00%2.05M
-8.38%7.62M
-6.42%6.01M
-2.49%3.92M
-2.99%1.63M
-31.08%8.32M
-33.43%6.43M
-45.33%4.02M
-Interest Income (Financial expense)
21.73%-13.57M
13.59%-9.81M
34.61%-3.19M
-578.48%-22M
-868.18%-17.34M
-809.57%-11.35M
-679.49%-4.87M
-1.15%-3.24M
32.97%-1.79M
35.17%-1.25M
Research and development
-12.68%50.8M
-3.13%39.17M
-20.01%14.56M
23.20%79.38M
15.21%58.18M
26.79%40.44M
56.11%18.21M
41.19%64.43M
58.49%50.5M
87.91%31.89M
Credit Impairment Loss
-3,189.02%-10.78M
-635.84%-7M
-722.76%-7.03M
89.62%-545.37K
93.11%-327.88K
74.27%-951.07K
49.66%-854.87K
-162.22%-5.25M
-29.85%-4.76M
-48.50%-3.7M
Asset Impairment Loss
----
----
----
10.69%-3.02M
----
----
----
15.56%-3.38M
----
----
Other net revenue
16.55%70.83M
33.55%51.05M
24.29%22.61M
12.38%83.89M
20.41%60.77M
17.01%38.23M
22.31%18.2M
45.79%74.65M
52.22%50.47M
58.30%32.67M
Fair value change income
----
----
----
----
----
----
----
-84.92%78.08K
-209.24%-455K
-248.54%-460.3K
Invest income
-65.98%-481.76K
93.97%-16.4K
284.66%289.93K
-107.18%-100.73K
-113.28%-290.25K
-112.79%-271.85K
-128.24%-157K
16.65%1.4M
172.66%2.18M
233.50%2.13M
-Including: Investment income associates
68.55%-74.85K
102.67%5.84K
-90.96%-343.06K
-133.68%-21.53K
-237.57%-238.02K
-246.03%-218.67K
-282.26%-179.65K
-56.97%63.92K
-53.29%173.01K
-16.42%149.74K
Asset deal income
42.78%343.31K
-2.88%233.52K
-97.14%6.88K
-83.81%279.13K
146.99%240.44K
184.80%240.44K
--240.44K
612.26%1.72M
-11,390.79%-511.73K
-4,496.23%-283.53K
Other revenue
33.69%81.75M
47.50%57.83M
54.75%29.35M
8.98%87.28M
13.22%61.15M
12.07%39.21M
19.40%18.97M
44.94%80.09M
39.69%54.01M
38.58%34.99M
Operating profit
49.36%503.94M
54.57%354.2M
55.16%176.43M
33.06%448.71M
39.41%337.41M
42.50%229.14M
37.16%113.71M
49.91%337.22M
47.39%242.02M
51.46%160.8M
Add:Non operating Income
936.44%589.41K
3,198,061.90%322.37K
1,046,230.51%93.96K
17.89%164.95K
-40.80%56.87K
-99.98%10.08
-99.95%8.98
-85.74%139.92K
-86.77%96.07K
-89.55%55.71K
Less:Non operating expense
683.74%9.75M
2,262.26%10.25M
2,905.76%10.24M
-83.15%2.23M
89.79%1.24M
-18.25%433.88K
-32.19%340.59K
266.18%13.23M
-55.00%655.2K
-32.26%530.71K
Total profit
47.16%494.79M
50.53%344.27M
46.68%166.29M
37.80%446.64M
39.24%336.22M
42.65%228.71M
37.55%113.37M
45.80%324.12M
47.71%241.46M
51.37%160.33M
Less:Income tax cost
54.46%67.4M
64.92%44.42M
59.40%22.18M
44.75%55.88M
62.44%43.64M
50.51%26.94M
44.01%13.91M
27.28%38.6M
19.81%26.87M
40.91%17.9M
Net profit
46.07%427.38M
48.61%299.85M
44.90%144.11M
36.86%390.76M
36.34%292.58M
41.66%201.78M
36.70%99.45M
48.72%285.52M
52.15%214.6M
52.79%142.43M
Net profit from continuing operation
46.07%427.38M
48.61%299.85M
44.90%144.11M
36.86%390.76M
36.34%292.58M
41.66%201.78M
36.70%99.45M
48.72%285.52M
52.15%214.6M
52.79%142.43M
Less:Minority Profit
3.21%5.9M
-7.76%3.79M
-15.39%1.69M
-37.46%7.83M
-46.24%5.72M
-45.49%4.11M
-50.14%2M
-0.48%12.51M
11.62%10.64M
13.30%7.55M
Net profit of parent company owners
46.93%421.48M
49.78%296.05M
46.14%142.42M
40.27%382.94M
40.65%286.87M
46.54%197.66M
41.76%97.45M
52.17%273.01M
55.08%203.96M
55.83%134.89M
Earning per share
Basic earning per share
47.14%0.6018
49.79%0.4221
46.15%0.203
22.22%0.55
22.05%0.409
27.17%0.2818
22.92%0.1389
55.17%0.45
55.07%0.3351
55.84%0.2216
Diluted earning per share
47.14%0.6018
49.79%0.4221
46.15%0.203
22.22%0.55
22.05%0.409
27.17%0.2818
22.92%0.1389
55.17%0.45
55.07%0.3351
55.84%0.2216
Other composite income
72.58%-33.44M
66.06%-32.13M
81.69%-8.82M
17.70%-159.48M
53.90%-121.96M
55.44%-94.68M
77.31%-48.2M
-246.08%-193.78M
-143.38%-264.56M
-216.36%-212.48M
Other composite income of parent company owners
72.58%-30.93M
66.06%-29.73M
81.69%-8.16M
17.70%-147.53M
53.90%-112.82M
55.44%-87.58M
77.31%-44.59M
-246.08%-179.25M
-143.45%-244.73M
-216.92%-196.55M
Other composite income of minority owners
72.58%-2.51M
66.06%-2.41M
81.69%-661.36K
17.70%-11.95M
53.90%-9.14M
55.44%-7.1M
77.31%-3.61M
-246.08%-14.53M
-142.63%-19.83M
-209.88%-15.93M
Total composite income
130.88%393.94M
149.98%267.71M
163.95%135.28M
152.10%231.28M
441.52%170.62M
252.89%107.09M
136.70%51.25M
-71.74%91.74M
-106.65%-49.96M
-125.40%-70.05M
Total composite income of parent company owners
124.39%390.55M
141.95%266.33M
153.94%134.25M
151.09%235.41M
526.95%174.05M
278.50%110.08M
141.38%52.87M
-68.97%93.75M
-105.87%-40.77M
-124.22%-61.67M
Total composite income of minority owners
199.18%3.4M
146.44%1.39M
163.79%1.03M
-105.26%-4.13M
62.76%-3.42M
64.40%-2.98M
86.45%-1.61M
-108.93%-2.01M
-116.40%-9.19M
-139.61%-8.38M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 39.59%2.04B41.21%1.43B35.75%672.9M7.61%1.94B8.97%1.46B13.02%1.01B12.81%495.7M23.86%1.81B24.66%1.34B28.28%894.95M
Operating revenue 39.59%2.04B41.21%1.43B35.75%672.9M7.61%1.94B8.97%1.46B13.02%1.01B12.81%495.7M23.86%1.81B24.66%1.34B28.28%894.95M
Other operating revenue ----91.52%5.17M-----71.49%5.2M-----87.76%2.7M----151.25%18.23M----347.14%22.07M
Total operating cost 35.64%1.61B37.12%1.13B29.71%519.09M2.27%1.58B3.08%1.19B7.01%820.54M7.75%400.19M20.17%1.54B21.68%1.15B25.27%766.82M
Operating cost 70.93%785.11M72.01%533.86M50.19%224.23M15.45%613.34M19.23%459.31M19.28%310.37M21.37%149.29M27.60%531.26M25.02%385.24M33.68%260.21M
Operating tax surcharges 28.58%21.22M33.25%16.02M12.52%4.95M22.60%24.98M12.20%16.5M10.89%12.02M-2.86%4.4M11.74%20.37M5.30%14.71M7.36%10.84M
Operating expense 14.41%684.12M16.07%488.28M20.04%250.54M-6.43%777.49M-4.36%597.94M1.58%420.67M0.48%208.72M17.27%830.87M18.57%625.19M20.78%414.12M
Administration expense 14.56%77.42M20.30%53.43M13.31%25.82M6.75%96.69M-6.43%67.58M-4.79%44.41M-0.44%22.79M5.62%90.58M22.44%72.22M10.86%46.65M
Financial expense 38.35%-6.91M23.43%-5.64M68.33%-1.02M-380.61%-14.25M-324.64%-11.21M-337.22%-7.37M-301.96%-3.22M-44.76%5.08M-30.70%4.99M-43.05%3.11M
-Interest expense (Financial expense) 9.02%6.56M4.73%4.1M26.00%2.05M-8.38%7.62M-6.42%6.01M-2.49%3.92M-2.99%1.63M-31.08%8.32M-33.43%6.43M-45.33%4.02M
-Interest Income (Financial expense) 21.73%-13.57M13.59%-9.81M34.61%-3.19M-578.48%-22M-868.18%-17.34M-809.57%-11.35M-679.49%-4.87M-1.15%-3.24M32.97%-1.79M35.17%-1.25M
Research and development -12.68%50.8M-3.13%39.17M-20.01%14.56M23.20%79.38M15.21%58.18M26.79%40.44M56.11%18.21M41.19%64.43M58.49%50.5M87.91%31.89M
Credit Impairment Loss -3,189.02%-10.78M-635.84%-7M-722.76%-7.03M89.62%-545.37K93.11%-327.88K74.27%-951.07K49.66%-854.87K-162.22%-5.25M-29.85%-4.76M-48.50%-3.7M
Asset Impairment Loss ------------10.69%-3.02M------------15.56%-3.38M--------
Other net revenue 16.55%70.83M33.55%51.05M24.29%22.61M12.38%83.89M20.41%60.77M17.01%38.23M22.31%18.2M45.79%74.65M52.22%50.47M58.30%32.67M
Fair value change income -----------------------------84.92%78.08K-209.24%-455K-248.54%-460.3K
Invest income -65.98%-481.76K93.97%-16.4K284.66%289.93K-107.18%-100.73K-113.28%-290.25K-112.79%-271.85K-128.24%-157K16.65%1.4M172.66%2.18M233.50%2.13M
-Including: Investment income associates 68.55%-74.85K102.67%5.84K-90.96%-343.06K-133.68%-21.53K-237.57%-238.02K-246.03%-218.67K-282.26%-179.65K-56.97%63.92K-53.29%173.01K-16.42%149.74K
Asset deal income 42.78%343.31K-2.88%233.52K-97.14%6.88K-83.81%279.13K146.99%240.44K184.80%240.44K--240.44K612.26%1.72M-11,390.79%-511.73K-4,496.23%-283.53K
Other revenue 33.69%81.75M47.50%57.83M54.75%29.35M8.98%87.28M13.22%61.15M12.07%39.21M19.40%18.97M44.94%80.09M39.69%54.01M38.58%34.99M
Operating profit 49.36%503.94M54.57%354.2M55.16%176.43M33.06%448.71M39.41%337.41M42.50%229.14M37.16%113.71M49.91%337.22M47.39%242.02M51.46%160.8M
Add:Non operating Income 936.44%589.41K3,198,061.90%322.37K1,046,230.51%93.96K17.89%164.95K-40.80%56.87K-99.98%10.08-99.95%8.98-85.74%139.92K-86.77%96.07K-89.55%55.71K
Less:Non operating expense 683.74%9.75M2,262.26%10.25M2,905.76%10.24M-83.15%2.23M89.79%1.24M-18.25%433.88K-32.19%340.59K266.18%13.23M-55.00%655.2K-32.26%530.71K
Total profit 47.16%494.79M50.53%344.27M46.68%166.29M37.80%446.64M39.24%336.22M42.65%228.71M37.55%113.37M45.80%324.12M47.71%241.46M51.37%160.33M
Less:Income tax cost 54.46%67.4M64.92%44.42M59.40%22.18M44.75%55.88M62.44%43.64M50.51%26.94M44.01%13.91M27.28%38.6M19.81%26.87M40.91%17.9M
Net profit 46.07%427.38M48.61%299.85M44.90%144.11M36.86%390.76M36.34%292.58M41.66%201.78M36.70%99.45M48.72%285.52M52.15%214.6M52.79%142.43M
Net profit from continuing operation 46.07%427.38M48.61%299.85M44.90%144.11M36.86%390.76M36.34%292.58M41.66%201.78M36.70%99.45M48.72%285.52M52.15%214.6M52.79%142.43M
Less:Minority Profit 3.21%5.9M-7.76%3.79M-15.39%1.69M-37.46%7.83M-46.24%5.72M-45.49%4.11M-50.14%2M-0.48%12.51M11.62%10.64M13.30%7.55M
Net profit of parent company owners 46.93%421.48M49.78%296.05M46.14%142.42M40.27%382.94M40.65%286.87M46.54%197.66M41.76%97.45M52.17%273.01M55.08%203.96M55.83%134.89M
Earning per share
Basic earning per share 47.14%0.601849.79%0.422146.15%0.20322.22%0.5522.05%0.40927.17%0.281822.92%0.138955.17%0.4555.07%0.335155.84%0.2216
Diluted earning per share 47.14%0.601849.79%0.422146.15%0.20322.22%0.5522.05%0.40927.17%0.281822.92%0.138955.17%0.4555.07%0.335155.84%0.2216
Other composite income 72.58%-33.44M66.06%-32.13M81.69%-8.82M17.70%-159.48M53.90%-121.96M55.44%-94.68M77.31%-48.2M-246.08%-193.78M-143.38%-264.56M-216.36%-212.48M
Other composite income of parent company owners 72.58%-30.93M66.06%-29.73M81.69%-8.16M17.70%-147.53M53.90%-112.82M55.44%-87.58M77.31%-44.59M-246.08%-179.25M-143.45%-244.73M-216.92%-196.55M
Other composite income of minority owners 72.58%-2.51M66.06%-2.41M81.69%-661.36K17.70%-11.95M53.90%-9.14M55.44%-7.1M77.31%-3.61M-246.08%-14.53M-142.63%-19.83M-209.88%-15.93M
Total composite income 130.88%393.94M149.98%267.71M163.95%135.28M152.10%231.28M441.52%170.62M252.89%107.09M136.70%51.25M-71.74%91.74M-106.65%-49.96M-125.40%-70.05M
Total composite income of parent company owners 124.39%390.55M141.95%266.33M153.94%134.25M151.09%235.41M526.95%174.05M278.50%110.08M141.38%52.87M-68.97%93.75M-105.87%-40.77M-124.22%-61.67M
Total composite income of minority owners 199.18%3.4M146.44%1.39M163.79%1.03M-105.26%-4.13M62.76%-3.42M64.40%-2.98M86.45%-1.61M-108.93%-2.01M-116.40%-9.19M-139.61%-8.38M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%